000 01290 a2200373 4500
005 20250513120925.0
264 0 _c19970703
008 199707s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/(sici)1097-0142(19970601)79:11<2154::aid-cncr13>3.0.co;2-v
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPisansky, T M
245 0 0 _aAn enhanced prognostic system for clinically localized carcinoma of the prostate.
_h[electronic resource]
260 _bCancer
_cJun 1997
300 _a2154-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCarcinoma
_xclassification
650 0 4 _aDisease-Free Survival
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aModels, Theoretical
650 0 4 _aMultivariate Analysis
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aPrognosis
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xclassification
650 0 4 _aRisk
650 0 4 _aSensitivity and Specificity
650 0 4 _aSurvival Analysis
700 1 _aKahn, M J
700 1 _aBostwick, D G
773 0 _tCancer
_gvol. 79
_gno. 11
_gp. 2154-61
856 4 0 _uhttps://doi.org/10.1002/(sici)1097-0142(19970601)79:11<2154::aid-cncr13>3.0.co;2-v
_zAvailable from publisher's website
999 _c9160098
_d9160098